The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Microbiome Modulators Market Research Report 2025
Synopsis
The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract.
The global Human Microbiome Modulators market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Microbiome Modulators is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Microbiome Modulators is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Microbiome Modulators in Digestive Health is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Microbiome Modulators include Bayer, BioGaia, Chr. Hansen Holding, DowDuPont, Ingredion, ISOThrive, Jarrow Formulas, DSM and Lallemand, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Microbiome Modulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Modulators.
Report Scope
The Human Microbiome Modulators market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Microbiome Modulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Microbiome Modulators companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
BioGaia
Chr. Hansen Holding
DowDuPont
Ingredion
ISOThrive
Jarrow Formulas
DSM
Lallemand
Sanofi
Segment by Type
Probiotics and Creams
Prebiotics and Dietary Supplements
Drugs
Segment by Application
Digestive Health
Immune Health
Oral Health
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome Modulators companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract.
The global Human Microbiome Modulators market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Microbiome Modulators is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Microbiome Modulators is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Microbiome Modulators in Digestive Health is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Microbiome Modulators include Bayer, BioGaia, Chr. Hansen Holding, DowDuPont, Ingredion, ISOThrive, Jarrow Formulas, DSM and Lallemand, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Microbiome Modulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Modulators.
Report Scope
The Human Microbiome Modulators market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Microbiome Modulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Microbiome Modulators companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
BioGaia
Chr. Hansen Holding
DowDuPont
Ingredion
ISOThrive
Jarrow Formulas
DSM
Lallemand
Sanofi
Segment by Type
Probiotics and Creams
Prebiotics and Dietary Supplements
Drugs
Segment by Application
Digestive Health
Immune Health
Oral Health
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome Modulators companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Modulators Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Probiotics and Creams
1.2.3 Prebiotics and Dietary Supplements
1.2.4 Drugs
1.3 Market by Application
1.3.1 Global Human Microbiome Modulators Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Digestive Health
1.3.3 Immune Health
1.3.4 Oral Health
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Modulators Market Perspective (2019-2030)
2.2 Human Microbiome Modulators Growth Trends by Region
2.2.1 Global Human Microbiome Modulators Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Microbiome Modulators Historic Market Size by Region (2019-2024)
2.2.3 Human Microbiome Modulators Forecasted Market Size by Region (2025-2030)
2.3 Human Microbiome Modulators Market Dynamics
2.3.1 Human Microbiome Modulators Industry Trends
2.3.2 Human Microbiome Modulators Market Drivers
2.3.3 Human Microbiome Modulators Market Challenges
2.3.4 Human Microbiome Modulators Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Modulators Players by Revenue
3.1.1 Global Top Human Microbiome Modulators Players by Revenue (2019-2024)
3.1.2 Global Human Microbiome Modulators Revenue Market Share by Players (2019-2024)
3.2 Global Human Microbiome Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Modulators Revenue
3.4 Global Human Microbiome Modulators Market Concentration Ratio
3.4.1 Global Human Microbiome Modulators Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Modulators Revenue in 2023
3.5 Human Microbiome Modulators Key Players Head office and Area Served
3.6 Key Players Human Microbiome Modulators Product Solution and Service
3.7 Date of Enter into Human Microbiome Modulators Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Modulators Breakdown Data by Type
4.1 Global Human Microbiome Modulators Historic Market Size by Type (2019-2024)
4.2 Global Human Microbiome Modulators Forecasted Market Size by Type (2025-2030)
5 Human Microbiome Modulators Breakdown Data by Application
5.1 Global Human Microbiome Modulators Historic Market Size by Application (2019-2024)
5.2 Global Human Microbiome Modulators Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Microbiome Modulators Market Size (2019-2030)
6.2 North America Human Microbiome Modulators Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Microbiome Modulators Market Size by Country (2019-2024)
6.4 North America Human Microbiome Modulators Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Microbiome Modulators Market Size (2019-2030)
7.2 Europe Human Microbiome Modulators Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Microbiome Modulators Market Size by Country (2019-2024)
7.4 Europe Human Microbiome Modulators Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Modulators Market Size (2019-2030)
8.2 Asia-Pacific Human Microbiome Modulators Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Microbiome Modulators Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Microbiome Modulators Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Microbiome Modulators Market Size (2019-2030)
9.2 Latin America Human Microbiome Modulators Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Microbiome Modulators Market Size by Country (2019-2024)
9.4 Latin America Human Microbiome Modulators Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Modulators Market Size (2019-2030)
10.2 Middle East & Africa Human Microbiome Modulators Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Microbiome Modulators Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Microbiome Modulators Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Human Microbiome Modulators Introduction
11.1.4 Bayer Revenue in Human Microbiome Modulators Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 BioGaia
11.2.1 BioGaia Company Detail
11.2.2 BioGaia Business Overview
11.2.3 BioGaia Human Microbiome Modulators Introduction
11.2.4 BioGaia Revenue in Human Microbiome Modulators Business (2019-2024)
11.2.5 BioGaia Recent Development
11.3 Chr. Hansen Holding
11.3.1 Chr. Hansen Holding Company Detail
11.3.2 Chr. Hansen Holding Business Overview
11.3.3 Chr. Hansen Holding Human Microbiome Modulators Introduction
11.3.4 Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2019-2024)
11.3.5 Chr. Hansen Holding Recent Development
11.4 DowDuPont
11.4.1 DowDuPont Company Detail
11.4.2 DowDuPont Business Overview
11.4.3 DowDuPont Human Microbiome Modulators Introduction
11.4.4 DowDuPont Revenue in Human Microbiome Modulators Business (2019-2024)
11.4.5 DowDuPont Recent Development
11.5 Ingredion
11.5.1 Ingredion Company Detail
11.5.2 Ingredion Business Overview
11.5.3 Ingredion Human Microbiome Modulators Introduction
11.5.4 Ingredion Revenue in Human Microbiome Modulators Business (2019-2024)
11.5.5 Ingredion Recent Development
11.6 ISOThrive
11.6.1 ISOThrive Company Detail
11.6.2 ISOThrive Business Overview
11.6.3 ISOThrive Human Microbiome Modulators Introduction
11.6.4 ISOThrive Revenue in Human Microbiome Modulators Business (2019-2024)
11.6.5 ISOThrive Recent Development
11.7 Jarrow Formulas
11.7.1 Jarrow Formulas Company Detail
11.7.2 Jarrow Formulas Business Overview
11.7.3 Jarrow Formulas Human Microbiome Modulators Introduction
11.7.4 Jarrow Formulas Revenue in Human Microbiome Modulators Business (2019-2024)
11.7.5 Jarrow Formulas Recent Development
11.8 DSM
11.8.1 DSM Company Detail
11.8.2 DSM Business Overview
11.8.3 DSM Human Microbiome Modulators Introduction
11.8.4 DSM Revenue in Human Microbiome Modulators Business (2019-2024)
11.8.5 DSM Recent Development
11.9 Lallemand
11.9.1 Lallemand Company Detail
11.9.2 Lallemand Business Overview
11.9.3 Lallemand Human Microbiome Modulators Introduction
11.9.4 Lallemand Revenue in Human Microbiome Modulators Business (2019-2024)
11.9.5 Lallemand Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Human Microbiome Modulators Introduction
11.10.4 Sanofi Revenue in Human Microbiome Modulators Business (2019-2024)
11.10.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Human Microbiome Modulators Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Probiotics and Creams
Table 3. Key Players of Prebiotics and Dietary Supplements
Table 4. Key Players of Drugs
Table 5. Global Human Microbiome Modulators Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Microbiome Modulators Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Human Microbiome Modulators Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Human Microbiome Modulators Market Share by Region (2019-2024)
Table 9. Global Human Microbiome Modulators Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Human Microbiome Modulators Market Share by Region (2025-2030)
Table 11. Human Microbiome Modulators Market Trends
Table 12. Human Microbiome Modulators Market Drivers
Table 13. Human Microbiome Modulators Market Challenges
Table 14. Human Microbiome Modulators Market Restraints
Table 15. Global Human Microbiome Modulators Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Human Microbiome Modulators Market Share by Players (2019-2024)
Table 17. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Modulators as of 2023)
Table 18. Ranking of Global Top Human Microbiome Modulators Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Human Microbiome Modulators Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Human Microbiome Modulators Product Solution and Service
Table 22. Date of Enter into Human Microbiome Modulators Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Microbiome Modulators Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Human Microbiome Modulators Revenue Market Share by Type (2019-2024)
Table 26. Global Human Microbiome Modulators Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Human Microbiome Modulators Revenue Market Share by Type (2025-2030)
Table 28. Global Human Microbiome Modulators Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Human Microbiome Modulators Revenue Market Share by Application (2019-2024)
Table 30. Global Human Microbiome Modulators Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Human Microbiome Modulators Revenue Market Share by Application (2025-2030)
Table 32. North America Human Microbiome Modulators Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Human Microbiome Modulators Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Human Microbiome Modulators Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Human Microbiome Modulators Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Human Microbiome Modulators Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Human Microbiome Modulators Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Human Microbiome Modulators Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Human Microbiome Modulators Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Human Microbiome Modulators Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Human Microbiome Modulators Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Human Microbiome Modulators Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Human Microbiome Modulators Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Human Microbiome Modulators Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Human Microbiome Modulators Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Human Microbiome Modulators Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bayer Company Detail
Table 48. Bayer Business Overview
Table 49. Bayer Human Microbiome Modulators Product
Table 50. Bayer Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
Table 51. Bayer Recent Development
Table 52. BioGaia Company Detail
Table 53. BioGaia Business Overview
Table 54. BioGaia Human Microbiome Modulators Product
Table 55. BioGaia Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
Table 56. BioGaia Recent Development
Table 57. Chr. Hansen Holding Company Detail
Table 58. Chr. Hansen Holding Business Overview
Table 59. Chr. Hansen Holding Human Microbiome Modulators Product
Table 60. Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
Table 61. Chr. Hansen Holding Recent Development
Table 62. DowDuPont Company Detail
Table 63. DowDuPont Business Overview
Table 64. DowDuPont Human Microbiome Modulators Product
Table 65. DowDuPont Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
Table 66. DowDuPont Recent Development
Table 67. Ingredion Company Detail
Table 68. Ingredion Business Overview
Table 69. Ingredion Human Microbiome Modulators Product
Table 70. Ingredion Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
Table 71. Ingredion Recent Development
Table 72. ISOThrive Company Detail
Table 73. ISOThrive Business Overview
Table 74. ISOThrive Human Microbiome Modulators Product
Table 75. ISOThrive Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
Table 76. ISOThrive Recent Development
Table 77. Jarrow Formulas Company Detail
Table 78. Jarrow Formulas Business Overview
Table 79. Jarrow Formulas Human Microbiome Modulators Product
Table 80. Jarrow Formulas Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
Table 81. Jarrow Formulas Recent Development
Table 82. DSM Company Detail
Table 83. DSM Business Overview
Table 84. DSM Human Microbiome Modulators Product
Table 85. DSM Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
Table 86. DSM Recent Development
Table 87. Lallemand Company Detail
Table 88. Lallemand Business Overview
Table 89. Lallemand Human Microbiome Modulators Product
Table 90. Lallemand Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
Table 91. Lallemand Recent Development
Table 92. Sanofi Company Detail
Table 93. Sanofi Business Overview
Table 94. Sanofi Human Microbiome Modulators Product
Table 95. Sanofi Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Modulators Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Microbiome Modulators Market Share by Type: 2023 VS 2030
Figure 3. Probiotics and Creams Features
Figure 4. Prebiotics and Dietary Supplements Features
Figure 5. Drugs Features
Figure 6. Global Human Microbiome Modulators Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Human Microbiome Modulators Market Share by Application: 2023 VS 2030
Figure 8. Digestive Health Case Studies
Figure 9. Immune Health Case Studies
Figure 10. Oral Health Case Studies
Figure 11. Others Case Studies
Figure 12. Human Microbiome Modulators Report Years Considered
Figure 13. Global Human Microbiome Modulators Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Human Microbiome Modulators Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Human Microbiome Modulators Market Share by Region: 2023 VS 2030
Figure 16. Global Human Microbiome Modulators Market Share by Players in 2023
Figure 17. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Modulators as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Human Microbiome Modulators Revenue in 2023
Figure 19. North America Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Human Microbiome Modulators Market Share by Country (2019-2030)
Figure 21. United States Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Human Microbiome Modulators Market Share by Country (2019-2030)
Figure 25. Germany Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Human Microbiome Modulators Market Share by Region (2019-2030)
Figure 33. China Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Human Microbiome Modulators Market Share by Country (2019-2030)
Figure 41. Mexico Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Human Microbiome Modulators Market Share by Country (2019-2030)
Figure 45. Turkey Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Bayer Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
Figure 48. BioGaia Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
Figure 49. Chr. Hansen Holding Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
Figure 50. DowDuPont Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
Figure 51. Ingredion Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
Figure 52. ISOThrive Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
Figure 53. Jarrow Formulas Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
Figure 54. DSM Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
Figure 55. Lallemand Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
Figure 56. Sanofi Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
